An Update on Alzheimer’s Research

Alzheimers ResearchAs one of the Commonwealth of Massachusetts' most experienced providers of senior care services, we are committed to helping educate the community on aging-related issues. One such issue is the state of Alzheimer's research and recent findings. The past few years have been promising ones. We have compiled a list of some of the clinical trials and studies that may be of interest to caregivers and families who have a loved one living with Alzheimer's disease or a related dementia.

Glucose Levels and Risk of Dementia

The results of this study were published in August in The New England Journal of Medicine. The program goal was to explore the role increased glucose levels and diabetes might play in dementia. What the trial found was that increased rates of glucose – even for those without diabetes – can lead to a greater risk of developing dementia.

Georgetown Leads National Resveratrol Study For Alzheimer's Disease

The Memory Disorder program at Georgetown University Medical Center is widely recognized for their innovative research. This national trial is in Phase II. Researchers are exploring the role resveratrol plays in Alzheimer's disease. Resveratrol is found in grapes, chocolate, tomatoes, peanuts and red wine.

Salk scientists develop drug that slows Alzheimer's in mice

An article published in Alzheimer's Research and Therapy this past May highlighted a drug developed by scientists at the Salk Institute for Biological Studies. Known as J147, this drug has been shown to reverse memory deficits and slow the progression of Alzheimer's disease in aged mice following short-term treatment. The team at Salk is currently recruiting patients for the next phase of the trial.

Cholesterol and Alzheimer's: A Big Step Forward

This area is one that you may have heard about before. Researchers have long been exploring the idea that high cholesterol may lead to Alzheimer's disease or a related dementia. Read more in this quick overview or read the full abstract in The Journal of Neuroscience.

We will continue to keep readers posted on these trials and others that we find. Be sure to subscribe to our blog to receive our updates.

 

 

    Post your comments...